Research also suggests that by facilitating weight loss, GLP-1 medication can indirectly reduce the burden on your other systemshelping to improve symptoms of PCOS, knee osteoporosis, sleep Apnea and even substance use disorders
The present results provide evidence for the association between obsessional thinking and GD that is differentiable from autistic trait measures
We are sensitive to the needs of our clients and will do everything in our power to seek justice and compensation on your behalf
Specific Kidney Effects GLP-1 medications produce several kidney-relevant improvements: Reduced albuminuria: The amount of albumin (protein) in urine, an early marker of kidney damage, typically decreases with GLP-1 treatment
Liraglutide, a once-daily human GLP-1 analog, added to a sulfonylurea (SU) offers significantly better glycemic control and favorable weight change compared with rosiglitazone and SU combination therapy in subjects with type 2 diabetes
